A non-covalent BTK inhibitor for some blood cancers
Pirtobrutinib
A targeted cancer medicine taken by mouth for certain types of lymphoma, blocking a signal that cancer cells need to grow.
What is Pirtobrutinib?
Pirtobrutinib is a specialist targeted cancer medicine used to treat some types of lymphoma, a cancer of certain white blood cells. It is a non-covalent BTK inhibitor, which means it blocks an enzyme called BTK that lymphoma cells rely on, and it can still work in some people after older BTK inhibitors have stopped helping. It is taken by mouth, usually once a day, and the main safety concerns are bleeding, an irregular heartbeat (atrial fibrillation), serious infections, falling blood counts and a higher chance of other cancers. It is used under specialist cancer supervision with regular blood tests.
Education and reference only. This is a plain-language guide to Pirtobrutinib — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Pirtobrutinib is a targeted cancer medicine used to treat certain types of lymphoma, which are cancers of particular white blood cells. It belongs to a group called BTK inhibitors but works in a slightly different way from the older ones: it is described as non-covalent, meaning it attaches more loosely to its target, which can let it keep working in some people whose cancer has stopped responding to earlier BTK inhibitors. It is taken by mouth as tablets, usually once a day, under the care of a specialist cancer team.
How it works
Lymphoma cells depend on signals passed through an enzyme called BTK (Bruton's tyrosine kinase) to survive and grow. Pirtobrutinib blocks BTK, switching off these survival signals so the cancer cells stop multiplying and many of them die. Because it binds to BTK in a non-covalent (more flexible) way, it can sometimes still work when changes in the cancer have made older BTK inhibitors stop helping. It is taken regularly to keep the signal switched off over time, and the specialist team monitors how the cancer responds.
Company & origin
Originated / developed by: Specialist manufacturer.
A specialist targeted cancer medicine used in the UK to treat certain types of lymphoma, often after other BTK inhibitors.
Practical use
How to take Pirtobrutinib
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- Take it by mouth, usually once a day, at about the same time each day as your specialist team advises.
- Swallow the tablets whole with water; do not stop or change the dose without specialist advice.
- Report any unusual bleeding or bruising straight away, and tell your team well before any surgery or dental work.
- Tell your team promptly about palpitations, fever or signs of infection, as these need prompt attention.
- Use effective contraception as advised, because this medicine can harm a developing baby.
Weighing it up
Advantages & disadvantages of Pirtobrutinib
Advantages
- A targeted, once-daily oral treatment that switches off a signal certain lymphoma cells need.
- Can still work in some people whose cancer has stopped responding to older BTK inhibitors.
- Taken at home as tablets rather than needing an infusion.
Disadvantages
- Can cause bleeding and bruising, and needs careful planning around surgery.
- Can trigger an irregular heartbeat and lower blood counts, so monitoring is needed.
- Carries a higher chance of serious infections and of other cancers, including skin cancers.
Practical use
Good to know
The most important safety point is bleeding: pirtobrutinib can make you bruise and bleed more easily, so report nosebleeds that will not stop, blood in the urine or stool, or any unusual bleeding, and your team will plan carefully around operations and dental work. It can cause an irregular heartbeat (atrial fibrillation), so tell your team about palpitations, a fluttering chest, dizziness or breathlessness. Because it affects the immune system, serious infections can occur, so report fevers and signs of infection promptly. It can lower blood counts, which is why regular blood tests are needed, and there is a higher chance of developing other cancers, including skin cancers, so protect your skin from the sun and report new lumps or skin changes. As with cancer medicines of this kind, it can harm a developing baby, so effective contraception is important during treatment.
Who should not take it / use with caution
- People who have had a serious allergic reaction to pirtobrutinib should not take it.
- It can harm a developing baby, so it is avoided in pregnancy and effective contraception is needed.
- It is used with care in people with bleeding problems, heart-rhythm conditions or significant infections, under specialist guidance.
Monitoring
- Regular blood tests to check blood counts and for signs of infection.
- Watching for bleeding, heart-rhythm changes and signs of infection.
- Skin checks over time, as the chance of skin and other cancers is higher.
Side effects
- Bruising and bleeding, which can range from minor to more serious.
- An irregular heartbeat (atrial fibrillation), tiredness and falling blood counts.
- Serious infections, which need prompt treatment.
- Rarely, new cancers, including skin cancers, so report new lumps or skin changes.
Key interactions
- Medicines that thin the blood or affect bleeding can add to the bleeding risk, so tell your team about them.
- Some medicines and supplements change how pirtobrutinib is broken down, so a full medicines list is important.
- Live vaccines are generally avoided during treatment because the immune system is affected.
Available as: Tablets taken by mouth.
Answers
Pirtobrutinib: frequently asked questions
What is pirtobrutinib used for?
It is a targeted cancer medicine used to treat certain types of lymphoma by blocking BTK, an enzyme that the cancer cells rely on to grow.
How is it different from older BTK inhibitors?
It attaches to BTK in a more flexible, non-covalent way, which can let it keep working in some people whose cancer has stopped responding to older BTK inhibitors.
Why does it cause bleeding?
It can affect how easily you bruise and bleed, so report unusual bleeding and tell your team before any surgery or dental work.
Can it affect my heart?
It can cause an irregular heartbeat called atrial fibrillation, so report palpitations, a fluttering chest, dizziness or breathlessness to your team.
Do I need to worry about infections?
Yes. It affects the immune system, so serious infections can occur; report fevers or signs of infection promptly and have your regular blood tests.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.